Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

50 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Intravenous or oral vinorelbine plus capecitabine as first-line treatment in HER2- metastatic breast cancer: joint analysis of 2 consecutive prospective phase II trials.
Strada MR, Palumbo R, Bernardo A, Riccardi A, Teragni C, Poggi G, Frascaroli M, Amatu A, Montagna B, Sottotetti F, Tagliaferri B, Bernardo G. Strada MR, et al. Among authors: sottotetti f. Clin Breast Cancer. 2012 Feb;12(1):30-9. doi: 10.1016/j.clbc.2011.11.001. Epub 2011 Dec 6. Clin Breast Cancer. 2012. PMID: 22154360 Clinical Trial.
Transhepatic arterial chemoembolization with oxaliplatin-eluting microspheres (OEM-TACE) for unresectable hepatic tumors.
Poggi G, Quaretti P, Minoia C, Bernardo G, Bonora MR, Gaggeri R, Ronchi A, Saluzzo CM, Azzaretti A, Rodolico G, Montagna M, Amatu A, Teragni C, Palumbo I, Traverso E, Tonini S, Villani L, Scelsi M, Baiardi P, Felisi MG, Sottotetti F, Tagliaferri B, Riccardi A. Poggi G, et al. Among authors: sottotetti f. Anticancer Res. 2008 Nov-Dec;28(6B):3835-42. Anticancer Res. 2008. PMID: 19192637 Free article. Clinical Trial.
OEM-TACE: a new therapeutic approach in unresectable intrahepatic cholangiocarcinoma.
Poggi G, Amatu A, Montagna B, Quaretti P, Minoia C, Sottani C, Villani L, Tagliaferri B, Sottotetti F, Rossi O, Pozzi E, Zappoli F, Riccardi A, Bernardo G. Poggi G, et al. Among authors: sottotetti f. Cardiovasc Intervent Radiol. 2009 Nov;32(6):1187-92. doi: 10.1007/s00270-009-9694-4. Cardiovasc Intervent Radiol. 2009. PMID: 19727937
Validation of an LC-MS/MS method for the determination of epirubicin in human serum of patients undergoing drug eluting microsphere-transarterial chemoembolization (DEM-TACE).
Sottani C, Leoni E, Porro B, Montagna B, Amatu A, Sottotetti F, Quaretti P, Poggi G, Minoia C. Sottani C, et al. Among authors: sottotetti f. J Chromatogr B Analyt Technol Biomed Life Sci. 2009 Nov 1;877(29):3543-8. doi: 10.1016/j.jchromb.2009.08.054. Epub 2009 Sep 19. J Chromatogr B Analyt Technol Biomed Life Sci. 2009. PMID: 19783235
Treatment of chronic hepatitis C in a patient affected by systemic sclerosis.
Poggi G, Villani L, Sottotetti F, Tagliaferri B, Montagna B, Amatu A, Bernardo G. Poggi G, et al. Among authors: sottotetti f. Gastroenterol Res Pract. 2009;2009:475390. doi: 10.1155/2009/475390. Epub 2009 Nov 17. Gastroenterol Res Pract. 2009. PMID: 19997512 Free PMC article.
Nanoparticle albumin-bound paclitaxel (nab-paclitaxel) as second-line chemotherapy in HER2-negative, taxane-pretreated metastatic breast cancer patients: prospective evaluation of activity, safety, and quality of life.
Palumbo R, Sottotetti F, Trifirò G, Piazza E, Ferzi A, Gambaro A, Spinapolice EG, Pozzi E, Tagliaferri B, Teragni C, Bernardo A. Palumbo R, et al. Among authors: sottotetti f. Drug Des Devel Ther. 2015 Apr 15;9:2189-99. doi: 10.2147/DDDT.S79563. eCollection 2015. Drug Des Devel Ther. 2015. PMID: 25931813 Free PMC article.
50 results